Persistent Asset Partners »

Sutro Biopharma shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $185k 7.4k 24.91

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Sutro Biopharma

BVF
Samsara BioCapital
Kynam Capital Management
OrbiMed Advisors
Affinity Asset Advisors
Vanguard Capital Management
RA Capital Management
Perceptive Advisors
Point72 Asset Management
ADAR1 Capital Management
Balyasny Asset Management
Woodline Partners
UBS Group
Vanguard Group
Acadian Asset Management

View all funds holding Sutro Biopharma